Data / Form D filings / Belhaven Biopharma Inc.
Belhaven Biopharma Inc.: Form D filing
Belhaven Biopharma Inc., a pharmaceuticals company in Chapel Hill, NC, filed a Form D with the SEC in 2025. The latest, on October 15, 2025, reports $32.3 million sold of a $32.3 million offering to 222 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 84406 Winslow, Chapel Hill, NC, 27517
- Phone
- (919) 656-8658
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1873965
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | New notice | $32,289,627 | $32,289,627 | 222 | Aug 4, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Wes Algon Wheeler | Director | |
| David Algon Neal | Executive Officer, Director | |
| Derek Algon Winstanly | Director | |
| Scott David Lyman | Executive Officer, Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Oct 13, 2025 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Belhaven Biopharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.